vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT
· Real-Time Price · USD
14.99
-0.07 (-0.46%)
At close: Jul 03, 2025, 2:10 PM
14.25
-4.94%
After-hours: Jul 03, 2025, 02:10 PM EDT
-0.46% (1D)
| Bid | 13.99 |
| Market Cap | 39.23M |
| Revenue (ttm) | 17K |
| Net Income (ttm) | -18.69M |
| EPS (ttm) | -2.8 |
| PE Ratio (ttm) | -5.35 |
| Forward PE | -4.16 |
| Analyst | Buy |
| Ask | 15.31 |
| Volume | 356 |
| Avg. Volume (20D) | 8,780 |
| Open | 15.07 |
| Previous Close | 15.06 |
| Day's Range | 14.83 - 15.08 |
| 52-Week Range | 12.12 - 26.99 |
| Beta | 0.60 |
About VTVT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VTVT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VTVT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+53.13%
vTv Therapeutics shares are trading higher after t...
Unlock content with
Pro Subscription
11 months ago
-24.53%
vTv Therapeutics shares are trading lower after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program.
